Evolution and world-wide distribution of varicella-zoster virus clades

Infection, Genetics and Evolution

Volumn 11, Issue 1, 2011, Pages 1-10

  Schmidt Chanasit, Jonas ^a   Sauerbrei, Andreas ^b  

^a BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^b Institute of Virology and Antiviral Therapy   (Germany)

Author keywords

Clade; Epidemiology; Recombination; Vaccine; Varicella zoster virus

Indexed keywords

CHICKENPOX VACCINE; OKA VACCINE; UNCLASSIFIED DRUG; VARICELLA ZOSTER VACCINE; VIRUS DNA; VIRUS VACCINE;

AMINO ACID SUBSTITUTION; CHICKENPOX; CLADISTICS; GENE SEQUENCE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HERPES ZOSTER; HOMOLOGOUS RECOMBINATION; HUMAN; MOLECULAR BIOLOGY; MOLECULAR EPIDEMIOLOGY; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINATION REACTION; VARICELLA ZOSTER VIRUS; VIRUS RECOMBINATION;

EVOLUTION, MOLECULAR; GENOME, VIRAL; GENOTYPE; HERPESVIRUS 3, HUMAN; PHYLOGENY; RECOMBINATION, GENETIC; VIRAL VACCINES;

HUMAN HERPESVIRUS 3;

EID: 78650187551     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2010.08.014     Document Type: Review

References (92)

1. Argaw T., Cohen J.I., Klutch M., Lekstrom K., Yoshikawa T., Asano Y., Krause P.R. Nucleotide sequences that distinguish Oka vaccine from parental Oka and other varicella zoster isolates. J. Infect. Dis. 2000, 181:1153-1157.
2. Arvin A.M., Moffat J.F., Redman R. Varicella-zoster virus: aspects of pathogenesis and host response to natural infection and varicella vaccine. Adv. Virus Res. 1996, 46:263-309.
3. Arvin, A.M., 1999. Chickenpox (varicella). In: Wolff, M.H., Schünemann, S., Schmidt, A. (Eds.), Varicella-Zoster Virus. Molecular Biology, Pathogenesis, and Clinical Aspects. Karger, Basel. Contrib. Microbiol. 3, 96-110.
4. Baiker A., Fabel K., Cozzio A., Zerboni L., Fabel K., Sommer M., Uchida N., He D., Weissman I., Arvin A.M. Varicella-zoster virus infection of human neural cells in vivo. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:10792-10797.
5. Barrett-Muir W., Nichols R., Breuer J. Phylogenetic analysis of varicella-zoster virus: evidence variation of varicella-zoster virus: evidence of intercontinental spread of genotypes and recombination. J. Virol. 2002, 76:1971-1979.
6. Barrett-Muir W., Scott F.T., Aaby P., John J., Matondo P., Chaudhry Q.L., Siqueira M., Poulsen A., Yamanishi K., Breuer J. Genetic variation of varicella-zoster virus: evidence for geographical separation of strains. J. Med. Virol. 2003, 70:S42-S47.
7. Bonanni P., Breuer J., Gershon A., Gershon M., Hryniewicz W., Papaevangelou V., Rentier B., Rümke H., Sadzot-Delvaux C., Senterre J., Weil-Oliver C., Wutzler P. Varicella vaccination in Europe-taking the practical approach. BMC Med. 2009, 7:26.
8. Breuer J. Monitoring virus strains variations following infection with VZV: is there a need and what are the implications of introducing the Oka vaccine?. Commun. Dis. Publ. Health 2003, 6:59-62.
9. Breuer J., Grose C., Norberg P., Tipples G., Schmid D.S. A proposal for a common nomenclature for viral clades from the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of Medicine and Dentistry. J. Gen. Virol. 2010, 91(July):821-828.
10. Carr M.J., McCormack G.P., Crowley B. Genetic variation in clinical varicella-zoster virus isolates collected in Ireland between 2002 and 2003. J. Med. Virol. 2004, 73:131-136.
11. Cohrs R.J., Gilden D.H., Gomi Y., Yamanishi K., Cohen J. Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of varicella-zoster virus. J. Virol. 2006, 80:2076-2082.
12. Dangler C.A., Henderson L.M., Bowman L.A., Deaver R.E. Direct isolation and identification of recombinant pseudorabies virus strains from tissues of experimentally co-infected swine. Am. J. Vet. Res. 1993, 54:540-545.
13. Davison A.J., Scott J.E. The complete sequence of varicella-zoster virus. J. Gen. Virol. 1986, 67:1759-1816.
14. Dayan G.H., Panero M.S., Debbag R., Urquiza A., Molina M., Prieto S., Del Carmen Perego M., Scagliotti G., Galimberti D., Carroli G., Wolff C., Schmid D.S., Loparev V., Guris D., Seward J. Varicella seroprevalence and molecular epidemiology of varicella-zoster virus in Argentina, 2002. J. Clin. Microbiol. 2004, 42:5698-5704.
15. D'Hondt E., Berge E., Colinet G., Duchene M., Peetermans J. Production and quality control of the Oka-strain live varicella vaccine. Postgrad. Med. J. 1985, 61(Suppl. 4):53-56.
16. Dohner D., Adams S.G., Gelb L.D. Recombination in tissue culture between varicella-zoster virus strains. J. Med. Virol. 1988, 24:329-341.
17. Faga B., Maury W., Bruckner D.A., Grose C. Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology 2001, 280:1-6.
18. Fairley C.K., Miller E. Varicella-zoster virus epidemiology-a changing scene?. J. Infect. Dis. 1996, 174(Suppl. 3):S314-S319.
19. Garnett G.P., Cox M.J., Bundy D.A., Didier J.M., St Catharine J. The age of infection with varicella-zoster virus in St Lucia, West Indies. Epidemiol. Infect. 1993, 110:361-372.
20. Gershon A., Mervish N., LaRussa P., Steinberg S., Lo S.H., Hodes D., Fikrig S., Bonagura V., Bakshi S. Varicella-zoster virus infection in children with underlying HIV infection. J. Infect. 1997, 176:1496-1500.
21. Gershon A.A. Live attenuated varicella vaccine. Int. J. Infect. Dis. 1997, 1:130-134.
22. Gershon A.A. The current status of live attenuated varicella vaccine. Arch. Virol. 2001, 17(Suppl.):1-6.
23. Gilden D., Nagel M.A., Mahalingam R., Mueller N.H., Braszeau E.A., Pugazhenthi S., Cohrs R.J. Clinical and molecular aspects of varicella-zoster virus infection. Future Neurol. 2009, 4:103-117.
24. Gomi Y., Imagawa T., Takahashi M., Yamanishi K. Oka varicella vaccine is distinguishable from its parental virus in DNA sequence of open reading frame 62 and its transactivation activity. J. Med. Virol. 2000, 61:497-503.
25. Gomi Y., Imagawa T., Takahashi M., Yamanishi K. Comparison of DNA sequence and transactivation activity of open reading frame 62 of Oka varicella vaccine and its parental viruses. Arch. Virol. 2001, 17(Suppl.):49-56.
26. Gomi Y., Sunamachi H., Mori Y., Nagaike K., Takahashi M., Yamanishi K. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J. Virol. 2002, 76:11447-11459.
27. Gomi Y., Ozaki T., Nishimura N., Narita A., Suzuki M., Ahn J., Watanabe N., Koyama N., Ushida H., Yasuda N., Nakane K., Funahashi K., Fuke I., Takamizawa A., Ishikawa T., Yamanishi K., Takahashi M. DNA sequence analysis of varicella-zoster virus gene 62 from subclinical infections in healthy children immunized with the Oka varicella vaccine. Vaccine 2008, 26:5627-5632.
28. Grose C., Tyler S., Peters G., Hiebert J., Stephens G.M., Ruyechan W.T., Jackson W., Storlie J., Tipples G.A. Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype. J. Virol. 2004, 78:6799-6807.
29. Hambleton S., Steinberg S., LaRussa P.S., Shapiro E.D., Gershon A.A. Risk of herpes zoster in adults immunized with varicella vaccine. J. Infect. Dis. 2008, 197:196-199.
30. Inoue H., Motani-Saitoh H., Sakurada K., Ikegaya H., Yajima D., Hayakawa M., Sato Y., Otsuka K., Kobayashi K., Nagasawa S., Iwase H. Determination of the geographical origin of unidentified cadavers based on geographical differences in genotype of varicella-zoster virus. J. Med. Virol. 2010, 82:903-908.
31. LaRussa P.S., Gershon A.A. Biologic and geographic differences between vaccine and clinical varicella-zoster virus isolates. Arch. Virol. Suppl. 2001, 41-48.
32. LaRussa P., Lungu O., Hardy I., Gershon A., Steinberg S.P., Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J. Virol. 1992, 66:1016-1020.
33. LaRussa P., Steinberg S., Meurice F., Gershon A. Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts. J. Infect. Dis. 1997, 176:1072-1075.
34. Leach D.R.F. Genetic Recombination 1996, Blackwell Science, Oxford.
35. Levin M.J., Dahl K.M., Weinberg A., Giller R., Patel A., Krause P.R. Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child. J. Infect. Dis. 2003, 188:954-959.
36. Liang G.L., Heidelberg K.A., Jacobson R.M., McEvoy M.T. Herpes zoster after varicella vaccination. J. Am. Acad. Dermatol. 1998, 38:761-763.
37. Liu J., Wang M., Gan L., Yang S., Chen J. Genotyping of clinical varicella-zoster virus isolates collected in China. J. Clin. Microbiol. 2009, 47:1418-1423.
38. Lokeshwar M.R., Agrawal A., Subbarao S.D., Chakraborty M.S., Ram Prasad A.V., Weil J., Bock H.L., Kanwal S., Shah R.C., Shah N. Age related seroprevalence of antibodies to varicella in India. Indian Pediatr. 2000, 37:714-719.
39. Loparev V.N., Argaw T., Krause P.R., Takayama M., Schmid D.S. Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR. J. Clin. Microbiol. 2000, 38:3156-3160.
40. Loparev V.N., Gonzalez A., Deleon-Carnes M., Tipples G., Fickenscher H., Torfason E.G., Schmid D.S. Global identification of three major genotypes of varicella-zoster virus: longitudinal clustering and strategies for genotyping. J. Virol. 2004, 78:8349-8358.
41. Loparev V., Martro E., Rubtcova E., Rodrigo C., Piette J.C., Caumes E., Vernant J.P., Schmid D.S., Fillet A.M. Toward universal varicella-zoster virus (VZV) genotyping: diversity of VZV strains from France and Spain. J. Clin. Microbiol. 2007, 45:559-563.
42. Loparev V.N., Rubtcova E.N., Bostik V., Govil D., Birch C.J., Druce J.C., Schmid D.S., Croxson M.C. Identification of five major and two minor genotypes of varicella-zoster virus strains: a practical two-amplicon approach used to genotype clinical isolates in Australia and New Zealand. J. Virol. 2007, 81:12758-12765.
43. Loparev V.N., Rubtcova E., Seward J.F., Levin M.J., Schmid D.S. DNA sequence variability in isolates recovered from patients with postvaccination rash or herpes zoster caused by Oka varicella vaccine. J. Infect. Dis. 2007, 195:502-510.
44. Loparev V.N., Rubtcova E.N., Bostik V., Tzaneva V., Sauerbrei A., Robo A., Sattler-Dornbacher E., Hanovcova I., Stepanova V., Splino M., Eremin V., Koskiniemi M., Vankova O.E., Schmid D.S. Distribution of varicella-zoster virus (VZV) wild type genotypes in northern and southern Europe: evidence for high conservation of circulating genotypes. Virology 2009, 383:216-225.
45. Lopez A.S., Burnett-Hartman A., Nambiar R., Ritz L., Owens P., Loparev V.N., Guris D., Schmid D.S. Transmission of a newly characterized strain of varicella-zoster virus from a patient with herpes zoster in a long-term-care facility, West Virginia, 2004. J. Infect. Dis. 2008, 197:646-653.
46. Martin D.P., Williamson C., Posada D. RDP2: recombination detection and analysis from sequence alignments. Bioinformatics 2005, 21:260-262.
47. McGeoch D.J., Cook S. Molecular phylogeny of the alphaherpesvirinae subfamily and a proposed evolutionary timescale. J. Mol. Biol. 1994, 238:9-22.
48. McGeoch D.J., Cook S., Dolan A., Jamieson F.E., Telford E.A. Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J. Mol. Biol. 1995, 247:443-458.
49. McGeoch D.J. Lineages of varicella-zoster virus. J. Gen. Virol. 2009, 90:963-969.
50. Moffat J.F., Zerboni L., Kinchington P.R., Grose C., Kaneshima H., Arvin A.M. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 1998, 72:965-974.
51. Moriuchi M., Moriuchi H., Straus S.E., Cohen J.I. Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA. Virology 1994, 200:297-300.
52. Norberg P., Liljeqvist J.A., Bergström T., Sammons S., Schmid D.S., Loparev V.N. Complete-genome phylogenetic approach to varicella-zoster virus evolution: genetic divergence and evidence for recombination. J. Virol. 2006, 80:9569-9576.
53. Parker S.P., Quinlivan M., Taha Y., Breuer J. Genotyping of varicella-zoster virus and the discrimination of Oka vaccine strains by TaqMan real-time PCR. J. Clin. Microbiol. 2006, 44:3911-3914.
54. Peters G.A., Tyler S.D., Grose C., Severini A., Gray M.J., Upton C., Tipples A. A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades. J. Virol. 2006, 80:9850-9860.
55. Quinlivan M., Hawrami K., Barrett-Muir W., Aaby P., Arvin A., Chow V.T., John T.J., Matondo P., Peiris M., Poulsen A., Siqueira M., Takahashi M., Talukder Y., Yamanishi K., Leedham-Green M., Scott F.T., Thomas S.L., Breuer J. The molecular epidemiology of varicella-zoster virus: evidence for geographic segregation. J. Infect. Dis. 2002, 186:888-894.
56. Quinlivan M.L., Gershon A.A., Steinberg S.P., Breuer J. Rashes occurring after immunization with a mixture of viruses in the Oka vaccine are derived from single clones of virus. J. Infect. Dis. 2004, 190:793-796.
57. Quinlivan M., Sengupta N., Breuer J. A case of varicella caused by co-infection with two different genotypes of varicella-zoster virus. J. Clin. Virol. 2009, 44:66-69.
58. Rodríguez-Castillo A., Vaughan G., Ramírez-González J.E., González-Durán E., Gudiño-Rosales J.C., Escobar-Gutiérrez A. Genetic variation of varicella-zoster virus strains circulating in Mexico city. J. Clin. Virol. 2009, 46:349-353.
59. Rodríguez-Castillo A., Vaughan G., Ramírez-González J.E., Escobar-Gutiérrez A. Simultaneous cocirculation of both European varicella-zoster virus genotypes (E1 and E2) in Mexico city. J. Clin. Microbiol. 2010, 48:1712-1715.
60. Roizman B., Desrosiers R.D., Fleckenstein B., Lopez C., Minson A.C., Suddert M.J. The family herpesviridae: an update. Arch. Virol. 1992, 123:425-449.
61. Sakaoka H., Kurita K., Iida Y., Takada S., Umene K., Kim Y.T., Ren C.S., Nahmias A.J. Quantitative analysis of genomic polymorphism of herpes simplex virus type 1 strains from six countries: studies of molecular evolution and molecular epidemiology of the virus. J. Gen. Virol. 1994, 75:513-527.
62. Sauerbrei A., Eichhorn U., Gawellek S., Egerer R., Schacke M., Wutzler P. Characterisation of varicella-zoster virus strains in Germany and differentiation from the Oka vaccine strain. J. Med. Virol. 2003, 71:313-319.
63. Sauerbrei A., Rubtcova E., Wutzler P., Schmid D.S., Loparev V. Genetic profile of Oka varicella vaccine virus variant isolated from an infant with zoster. J. Clin. Microbiol. 2004, 42:5604-5608.
64. Sauerbrei A., Zell R., Harder M., Wutzler P. Genotyping of different varicella vaccine strains. J. Clin. Virol. 2006, 37:109-117.
65. Sauerbrei A., Wutzler P. Herpes simplex and varicella-zoster virus infections during pregnancy-current concepts of prevention, diagnosis and therapy. Part 2: Varicella-zoster virus infections. Microbiol. Immunol. 2007, 196:95-102.
66. Sauerbrei A., Wutzler P. Different genotype pattern of varicella-zoster virus obtained from patients with varicella and zoster in Germany. J. Med. Virol. 2007, 79:1025-1031.
67. Sauerbrei A., Zell R., Philipps A., Wutzler P. Genotypes of varicella-zoster virus wild-type strains in Germany. J. Med. Virol. 2008, 80:1123-1130.
68. Sauerbrei A., Bohn K., Zell R., Wutzler P. Variability of the immediate early gene 62 in German varicella-zoster virus wild-type strains. J. Clin. Microbiol. 2009, 47:3717-3720.
69. Schmidt-Chanasit J., Stürmer M., Hahn A., Schäd S.G., Gross G., Ulrich R.G., Heckel G., Doerr H.W. Novel genotyping approach for varicella-zoster virus strains from Germany. J. Clin. Microbiol. 2007, 45:3540-3545.
70. Schmidt-Chanasit J., Bleymehl K., Schäd S.G., Gross G., Ulrich R.G., Doerr H.W. Novel varicella-zoster virus glycoprotein E gene mutations associated with genotypes A and D. J. Clin. Microbiol. 2008, 46:325-327.
71. Schmidt-Chanasit J., Olschläger S., Günther S., Jaeger G., Bleymehl K., Schäd S.G., Heckel G., Ulrich R.G., Doerr H.W. Molecular analysis of varicella-zoster virus strains circulating in Tanzania demonstrating the presence of genotype M1. J. Clin. Microbiol. 2008, 46:3530-3533.
72. Schmidt-Chanasit J., Olschläger S., Bialonski A., Heinemann P., Bleymehl K., Gross G., Günther S., Ulrich R.G., Doerr H.W. Novel approach to differentiate subclades of varicella-zoster virus genotypes E1 and E2 in Germany. Virus Res. 2009, 145:347-349.
73. Sengupta N., Taha Y., Scott F.T., Leedham-Green E., Quinlivan M., Breuer J. Varicella-zoster virus genotypes in East London: a prospective study in patients with herpes zoster. J. Infect. Dis. 2007, 196:1014-1020.
74. Sergeev N., Rubtcova E., Chizikov V., Schmid D.S., Loparev V.N. New mosaic subgenotype of varicella-zoster virus in the USA: VZV detection and genotyping by oligonucleotide-microarray. J. Virol. Methods 2006, 136:8-16.
75. Sharrar R.G., LaRussa P., Galea S.A., Steinberg S.P., Sweet A.R., Keatley R.M., Wells M.E., Stephenson W.P., Gershon A.A. The postmarketing safety profile of varicella vaccine. Vaccine 2001, 19:916-923.
76. Shiraki K., Horiuchi K., Asano Y., Yamanishi K., Takahashi M. Differentiation of Oka varicella vaccine strain from wild varicella-zoster virus strains isolated from vaccinees and household contact. J. Med. Virol. 1991, 33:128-132.
77. Soong W., Schultz J.C., Patera A.C., Sommer M.H., Cohen J.I. Infection of human T lymphocytes with varicella-zoster virus: an analysis with viral mutants and clinical isolates. J. Virol. 2000, 74:1864-1870.
78. Takahashi M., Otsuka T., Okuno Y., Asano Y., Yazaki T., Isomura S. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974, ii:1288-1290.
79. Takahashi M. The varicella vaccine: vaccine development. Infect. Dis. Clin. North Am. 1996, 10:469-488.
80. Takayama M., Takayama N. New method of differentiating wild-type varicella-zoster virus (VZV) strains from Oka varicella vaccine strain by VZV ORF-based PCR and restriction fragment length polymorphism analysis. J. Clin. Virol. 2004, 29:113-119.
81. Thiry E., Meurens F., Muylkens B., McVoy M., Gogev S., Thiry J., Vanderplasschen A., Epstein A., Keil G., Schynts F. Recombination in alphaherpesviruses. Rev. Med. Virol. 2005, 15:89-103.
82. Toi C.S., Dwyer D.E. Prevalence of varicella-zoster virus genotypes in Australia characterized by high-resolution melt analysis and ORF22 gene analyses. J. Med. Microbiol. 2010, 59:935-940.
83. Tyler J.K., Everett R.D. The DNA binding domain of the varicella-zoster virus gene 62 protein interacts with multiple sequences which are similar to the binding site of the related protein of herpes simplex virus type 1. Nucleic Acid Res. 1993, 21:513-522.
84. Tyler S.D., Peters G.A., Grose C., Severini A., Gray M.J., Upton C., Tipples G.A. Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences. Virology 2007, 359:447-458.
85. Uebe B., Sauerbrei A., Burdach S., Horneff G. Herpes zoster by reactivated vaccine varicella-zoster virus in a healthy child. Eur. J. Pediatr. 2002, 161:442-444.
86. Umene K., Sakaoka H. Evolution of herpes simplex virus type 1 under herpesviral evolutionary processes. Arch. Virol. 1999, 144:637-656.
87. Vázquez M., Shapiro E.D. Varicella vaccine and infection with varicella-zoster virus. N. Engl. J. Med. 2005, 352:439-440.
88. Wagenaar T.R., Chow V.T., Buranathai C., Thawatsupha P., Grose C. The out of Africa model of varicella-zoster virus evolution: single nucleotide polymorphisms and private alleles distinguish Asian clades from European/North American clades. Vaccine 2003, 21:1072-1081.
89. World Health Organization The WHO position paper on varicella vaccines. Wkly. Epidemiol. Rec. 1998, 73:241-248.
90. Wutzler P., Färber I., Wagenpfeil S., Bisanz H., Tischer A. Seroprevalence of varicella-zoster virus in the German population. Vaccine 2001, 20:121-124.
91. Yamanishi K. Molecular analysis of the Oka vaccine strain of varicella-zoster virus. J. Infect. Dis. 2008, 197:S45-S48.
92. Zerboni L., Hincliffe S., Sommer M.H., Ito H., Besser J., Stamatis S., Cheng J., Distefano D., Kraiouchkine N., Shaw A., Arvin A.M. Analysis of varicella-zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model. Virology 2005, 332:337-346.